Posttransplant Guillain Barre Syndrome

Area of Science:

• Hematology
• Neurology
• Immunology

Background:

• Severe aplastic anaemia necessitates allogeneic hematopoietic stem cell transplantation (HSCT) for treatment.
• HSCT involves complex procedures with potential post-transplant complications.
• Guillain Barre Syndrome (GBS) is a rare neurological disorder affecting the peripheral nervous system.

Observation:

• A patient with severe aplastic anaemia developed GBS 10 weeks post-HSCT.
• The onset of GBS followed infections including pneumonia, herpes labialis, and oral candidiasis.
• The patient received treatment comprising ventilatory support, intravenous immunoglobulin (IVIg), and antimicrobials.

Findings:

• The case highlights a potential association between HSCT and the development of GBS.
• Prompt and appropriate medical intervention is crucial for managing post-HSCT neurological complications.
• Successful recovery from GBS was achieved with a combination of supportive care and immunomodulatory therapy.

Implications:

• This case underscores the importance of vigilant monitoring for neurological complications after HSCT.
• Understanding the triggers and management of GBS post-HSCT can improve patient outcomes.
• Further research may elucidate the specific mechanisms linking HSCT and GBS development.